CITATION STYLE
Vermeire, S. (2017). Biologic therapy of ulcerative colitis: Natalizumab, vedolizumab, etrolizumab (rHUMab beta 7), anti-MAdCAM. In Crohn’s Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach: Second Edition (pp. 449–454). Springer International Publishing. https://doi.org/10.1007/978-3-319-33703-6_45
Mendeley helps you to discover research relevant for your work.